LA
Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
$67.17 +0.00% (+$0.00)
Market Cap 2.95B €
P/E Ratio 15.95x
Div. Yield 3.26%
ROE 27.82%
Bulios Fair Price
$34.44
48.7% downside
Current Price
$67.17
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LABFF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
62 /100
Fair P/E 15.95x
EV/EBITDA 10.74x
PEG 8.21x
Growth
9 /100
Declining EPS growth 9.66%
Rev. growth 3.13%
Book val. growth 8.50%
Profitability
97 /100
Strong Gross margin 64.02%
Net margin 23.94%
FCF margin 22.85%
Quality
86 /100
Excellent ROIC 15.23%
ROE 27.82%
Asset turnover 0.69x
Debt
100 /100
Low Debt/Equity 0.15x
Current ratio 2.05x
Net debt/EBITDA -0.07x
Stability
77 /100
Stable Beta 0.23x
Rev. volatility 4.70%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LABFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Juan Lopez-Belmonte Encina
Employees
2,232
Headquarters
Pozuelo de Alarcón
Upcoming events
05 NOV
Earnings
Upcoming earnings report